Patent details

Basic Information

Publication number:

EP3512548

PCT Application Number:

AU2017050998

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP178499224

PCT Publication Number:

WO2018049474

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIBODY AND CHECKPOINT INHIBITOR COMBINATION THERAPY

French Title of Invention:

POLYTHÉRAPIE À BASE D'UN ANTICORPS ET D'UN INHIBITEUR DE POINT DE CONTRÔLE

German Title of Invention:

KOMBINATIONSTHERAPIE AUS ANTIKÖRPER UND CHECKPOINT-INHIBITOR

SPC Number:

Dates

Filing date:

14/09/2017

Grant date:

22/03/2023

EP Publication Date:

24/07/2019

PCT Publication Date:

22/03/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

22/03/2023

EP B1 Publication Date:

22/03/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/09/2023

Expiration date:

14/09/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/03/2023

 

 

Name:

Bionomics Limited

Address:

200 Greenhill Road, Eastwood, South Australia 5063, Australia (AU)

Inventor

1

Name:

INGLIS, Daniel John

Address:

Australia (AU)

2

Name:

REYES, Christopher L.

Address:

Australia (AU)

3

Name:

LAVRANOS, Tina Christine

Address:

Australia (AU)

Priority

Priority Number:

2016903724

Priority Date:

16/09/2016

Priority Country:

Australia (AU)

Classification

IPC classification:

A61K 39/395; A61P 35/00; C07K 16/28; A61K 31/343; A61K 31/4745; A61K 31/513; A61K 31/519; A61K 45/06;

Publication

European Patent Bulletin

Issue number:

202312

Publication date:

22/03/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages